Medcorpus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.49%
- Profit Growth 131.77%
- Ebitda 22.75%
- Net Worth 15.38%
- Total Assets 37.82%
About Medcorpus Pharmaceuticals
Medcorpus Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2016 (Eight years and four months 23 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Gurumurthy, Pragadeeswaran, and Thangaraj Subbiah serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2016PTC112571
-
Company No.
112571
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Medcorpus Pharmaceuticals Private Limited offer?
Medcorpus Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Nutritional Supplements, Respiratory System Drugs, Anti Asthma Drug, Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Antihistamines, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Medcorpus Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Gurumurthy
|
Director | 19-Sep-2016 | Current |
|
Pragadeeswaran
|
Director | 19-Sep-2016 | Current |
|
Thangaraj Subbiah
|
Director | 19-Sep-2016 | Current |
Financial Performance of Medcorpus Pharmaceuticals.
Medcorpus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.49% increase. The company also saw a substantial improvement in profitability, with a 131.77% increase in profit. The company's net worth Soared by an impressive increase of 15.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medcorpus Pharmaceuticals?
In 2018, Medcorpus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medcorpus Pharmaceuticals?
Unlock and access historical data on people associated with Medcorpus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcorpus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcorpus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.